Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 2Phase 4 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 160Gastrointestinal 46Thoracic 40Breast 33Gynecologic 29Genitourinary 28Head & Neck 25Dermatologic 25CNS 19Lymphoid 13Endocrine 10Other solid neoplasm 8NET 6Plasma cell 5Other hematologic neoplasm 4Myeloid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 32Leukemia, Myeloid, Acute 31Myelodysplastic Syndromes 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia 21Leukemia, Myelomonocytic, Chronic 18Lymphoma, Non-Hodgkin 17Myeloproliferative Disorders 15Thrombocytopenia 13Anemia, Aplastic 13Anemia 12Hodgkin Disease 11Hematologic Neoplasms 11Multiple Myeloma 10Lymphoma 10Leukemia, Lymphocytic, Chronic, B-Cell 9Anemia, Refractory 9Lymphoma, Mantle-Cell 8Lymphoma, Follicular 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Fanconi Anemia 7Congenital Abnormalities 7Blast Crisis 7Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Accelerated Phase 6Cytopenia 6Neoplasms 5Lymphoma, B-Cell, Marginal Zone 5Burkitt Lymphoma 5Primary Immunodeficiency Diseases 4

Interventions

SRA737 1Gemcitabine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Sarcoma × Classical hematology × Clear all
NCT02797977 2023-06-22

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
153 enrolled
Classical hematologySarcomaThoracic

Fanconi Anemia, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡